IDX184, the firm'...
You must be logged in to view the whole article.
Click here if you require signing up
DNDi, Abbott broaden neglected tropical diseases collaboration
Trius Therapeutics plans stock offering
Trius gets USD5m milestone from Bayer for successful close of Phase III study with tedizolid
NovaBay close to launching Phase IIb trial of NVC-422 in adenoviral conjunctivitis
Brazil adds IPV of Sanofi Pasteur in national immunisation programme
MGB Biopharma selects Almac for contract manufacturing of antibacterial compound
Life Technologies forms JV with Chinese DaAn Gene for molecular diagnostic assays
Intercell, SSI advance TB vaccine candidate into Phase II study
Pergamum launches Phase II trial of DPK-060 in external otitis patients
Advanced BioNutrition, Chile's Centrovet agree to expand ISAV vaccine
Optimer Pharmaceuticals COO calls it quits
FDA accepts Starpharma's Phase III trial design for VivaGel for BV treatment
The Gates Foundation awards USD500,000 to IDRI
Elis Pharma to market Apricus Bio's MycoVa in Middle East, Gulf states